indazoles has been researched along with arry-371797 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JC; Homma, S; Iwata, S; Morrow, J; Muchir, A; Worman, HJ; Wu, W | 1 |
| Angeli, FS; Judge, DP; Lakdawala, NK; Lee, PA; Li, H; MacRae, CA; Mestroni, L; Oliver, C; Taylor, MRG | 1 |
| Ashley, EA; Hershberger, RE; Judge, DP; Lakdawala, NK; Lee, PA; MacRae, CA; Mestroni, L; Moses, J; Oliver, C; Sandor, V; Saunders, ME; Taylor, MRG; Wheeler, MT | 1 |
1 trial(s) available for indazoles and arry-371797
| Article | Year |
|---|---|
Efficacy and Safety of ARRY-371797 in
Topics: Cardiomyopathy, Dilated; Humans; Indazoles; Lamin Type A; Stroke Volume; Ventricular Function, Left | 2023 |
2 other study(ies) available for indazoles and arry-371797
| Article | Year |
|---|---|
Abnormal p38α mitogen-activated protein kinase signaling in dilated cardiomyopathy caused by lamin A/C gene mutation.
Topics: Adolescent; Animals; Cardiomyopathy, Dilated; Cells, Cultured; Ethylenediamines; Female; Humans; Indazoles; Lamin Type A; Male; Mice; Mice, Transgenic; Middle Aged; Mitogen-Activated Protein Kinase 14; Mutation, Missense; Myocytes, Cardiac; Signal Transduction; Young Adult | 2012 |
Long-Term Efficacy and Safety of ARRY-371797 (PF-07265803) in Patients With Lamin A/C-Related Dilated Cardiomyopathy.
Topics: Adult; Cardiomyopathy, Dilated; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Ethylenediamines; Female; Humans; Indazoles; Lamin Type A; Male; Middle Aged; Mitogen-Activated Protein Kinase 14; Natriuretic Peptide, Brain; Randomized Controlled Trials as Topic | 2022 |